Funded Projects

Explore our currently funded projects. You may search with all three fields, then focus your results by applying any of the dropdown filters. After customizing your search, you may download results and even save your specific search for later.

Reset
Project # Project Title Research Focus Area Research Program Administering IC Institution(s) Investigator(s) Location(s) Year Awarded
1R44DA061722-01
NX90: A Treatment for Overdose Caused by High Potency Opioids Cross-Cutting Research Small Business Programs NIDA SERODOPA THERAPEUTICS, INC. VORONKOV, MICHAEL V Gainesville, FL 2024
NOFO Title: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
NOFO Number: PA-23-230
1R01DA060796-01
Virtual Reality Treatment for Chronic Pain and OUD In Opioid Treatment Programs: A Randomized Controlled Trial New Strategies to Prevent and Treat Opioid Addiction NIDA ALBERT EINSTEIN COLLEGE OF MEDICINE PEREZ, HECTOR RUBEN Bronx, NY 2024
NOFO Title: Research Opportunities for New and ""At-Risk"" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
NOFO Number: PAR-22-181
1U01DA061643-01
Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use Disorder Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose NIDA NIRSUM LABORATORIES, INC. SHAH, NIKEJ (contact); SORENSON, MARK New York, NY 2024
NOFO Title: Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
NOFO Number: PAR-22-202
1K23DA061045-01
Implementing a Digital Therapeutic to Address Substance Use Disorders among People who Are Incarcerated Training the Next Generation of Researchers in HEAL NIDA YALE UNIVERSITY LOYA, JENNIFER M New Haven, CT 2024
NOFO Title: HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required)
NOFO Number: PAS-22-207
4UH3DA050323-02
Cannabidiol in the treatment of opioid use disorder Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose NIDA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI HURD, YASMIN L New York, NY 2024
NOFO Title: Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)
NOFO Number: RFA-DA-19-002
4R33DA057660-02
Fatal Overdose Review Teams - Research to Enhance Surveillance Systems (FORTRESS) Cross-Cutting Research Translating Data 2 Action to Prevent Overdose NIDA INDIANA UNIVERSITY INDIANAPOLIS AALSMA, MATTHEW (contact); RAY, BRADLEY; REDA, KHAIRI Indianapolis, IN 2024
NOFO Title: HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-22-051
1R61DA061335-01
Development and Evaluation of a Mobile Health Intervention for Co-Morbid Opioid Use Disorder and Posttraumatic Stress Disorder During Community Re-entry Translation of Research to Practice for the Treatment of Opioid Addiction Optimizing the Quality, Reach, and Impact of Addiction Services NIDA UNIVERSITY OF RHODE ISLAND WEISS, NICOLE HOLLAND Kingston, RI 2024
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053
1R61DA062351-01
A Bundled Intervention to End Opioid Overdoses by Increasing Treatment Uptake Post Emergency Department Discharge Translation of Research to Practice for the Treatment of Opioid Addiction Optimizing the Quality, Reach, and Impact of Addiction Services NIDA UNIVERSITY OF ALABAMA AT BIRMINGHAM LI, LI Birmingham, AL 2024
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053
1R43DA061400-01
Remote and Non-Invasive Opioid Use Screening to Lower Barriers to Substance Use Disorder Diagnosis and Treatment Cross-Cutting Research Small Business Programs NIDA TENVOS, INC. SEIILOVA-OLSON, RIMA West Sacramento, CA 2024
NOFO Title: Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R43/R44 Clinical Trial Optional)
NOFO Number: RFA-DA-24-018
1R21DA062022-01
Neuropeptide S Receptor 1 as a Novel Target for Reducing Opioid Self-Administration and Opioid Relapse Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose NIDA UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER TUNSTALL, BRENDAN Memphis, TN 2024
NOFO Title: HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
NOFO Number: RFA-DA-24-064
1UG3DA062106-01
Targeting Treatment-Resistant OUD with Ketamine-Assisted Mindfulness-Oriented Recovery Enhancement Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose NIDA UNIVERSITY OF UTAH GARLAND, ERIC LEE (contact); NUNES, EDWARD V Salt Lake City, UT 2024
NOFO Title: Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional)
NOFO Number: RFA-DA-25-058
4U01HL150596-02
The Collaboration Linking Opioid Use Disorder and Sleep ("CLOUDS") Study New Strategies to Prevent and Treat Opioid Addiction Sleep Dysfunction as a Core Feature of Opioid Use Disorder and Recovery NHLBI YALE UNIVERSITY YAGGI, HENRY KLAR (contact); BARRY, DECLAN T; REDEKER, NANCY S; SCHEINOST, DUSTIN New Haven, CT 2024
NOFO Title: HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional)
NOFO Number: RFA-HL-19-029
1DP2DA062283-01
Novel Econometric Research Designs (NERD) to Help End Addiction Long-term Training the Next Generation of Researchers in HEAL NIDA WEILL CORNELL MEDICINE JALALI, ALI New York, NY 2024
NOFO Title: Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
NOFO Number: RFA-TR-23-011
3OT2OD030208-01S3
Helping to End Addiction Long-term (HEAL) Data Platform Cross-Cutting Research OD UNIVERSITY OF CHICAGO GROSSMAN, ROBERT L Chicago, IL 2024
NOFO Title: HEAL RfN FY2020
NOFO Number: OTA-20-007
1OT2DA061082-01
Our Healing Journey: A Cultural and Traditional Response to the Opioid Epidemic Translation of Research to Practice for the Treatment of Opioid Addiction Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain NIDA EASTERN SHOSHONE TRIBE WEBB, KELLIE (contact); HIRCHAK, KATHERINE Fort Washakie, WY 2024
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007
1OT2DA061146-01
PERSON-CENTERED RESEARCH ON CULTURE AS HEALTH (PERCH) An Indigenous Model of Wellness Translation of Research to Practice for the Treatment of Opioid Addiction Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain NIDA GREAT LAKES INTER-TRIBAL COUNCIL, INC. LENZ, KADE (contact); DENSLINGER, CHRISTINA Lac du Flambeau, WI 2024
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007
4U01DA047982-02
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults Translation of Research to Practice for the Treatment of Opioid Addiction Justice Community Opioid Innovation Network (JCOIN) NIDA NEW YORK UNIVERSITY SCHOOL OF MEDICINE LEE, JOSHUA D (contact); FARABEE, DAVID J; GRYCZYNSKI, JAN; MARSCH, LISA A; SPRINGER, SANDRA ANN; WADDELL, ELIZABETH NEEDHAM New York, NY 2024
NOFO Title: NIH Research Project Grant (Parent R01 Clinical Trial Required)
NOFO Number: PA-18-345
3R44DA049685-03S1
Noninvasive Brain Stimulation for Treating Addiction (Supplement) Cross-Cutting Research Small Business Programs NIDA HIGHLAND INSTRUMENTS, INC. WAGNER, TIMOTHY ANDREW (contact); DIPIETRO, LAURA Sharon, MA 2024
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272
3K23DA055695-03S1
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: A Pilot Randomized Controlled Trial Training the Next Generation of Researchers in HEAL NIDA RHODE ISLAND HOSPITAL BERK, JUSTIN Providence, RI 2024
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272
1R34DA059770-01
Addressing racial disparities in opioid overdose deaths using an open source peer recovery coach training and multimodal mobile health platform New Strategies to Prevent and Treat Opioid Addiction NIDA FRIENDS RESEARCH INSTITUTE, INC. TOFIGHI, BABAK (contact); LEKAS, HELEN-MARIA; LEWIS, CRYSTAL FULLER Baltimore, MD 2024
NOFO Title: Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
NOFO Number: PA-21-110
3R34DA057604-01S1
Research supplement to promote diversity within the context of research involving recovery community centers Training the Next Generation of Researchers in HEAL NIDA MASSACHUSETTS GENERAL HOSPITAL HOEPPNER, BETTINA B Somerville, MA 2024
NOFO Title: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
NOFO Number: PA-23-189
4UH3DA047793-03
tDCS to Decrease Opioid Relapse Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose NIDA BUTLER HOSPITAL ABRANTES, ANA M (contact); STEIN, MICHAEL D Providence, RI 2024
NOFO Title: Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional)
NOFO Number: PAR-18-494
1UG3DA061620-01
Registration Development Program for LUCEMYRA (Lofexidine) Label Expansion for Opioid Withdrawal Treatment in Adolescents Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose NIDA USWM, LLC MASSEY, VERONICA LYNCH (contact); SCHMIDT, LEE Louisville, KY 2024
NOFO Title: Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
NOFO Number: PAR-22-200
1R61DA062217-01
A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk New Strategies to Prevent and Treat Opioid Addiction NIDA BOSTON MEDICAL CENTER BAGLEY, SARAH M (contact); YULE, AMY Boston, MA 2024
NOFO Title: Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)
NOFO Number: PAR-24-062
1R34DA061589-01
Brief Digitally-Enhanced Intervention for Managing Emotional Pain and Reducing Alcohol Use during Medication for OUD Translation of Research to Practice for the Treatment of Opioid Addiction NIDA OHIO STATE UNIVERSITY GORKA, STEPHANIE (contact); ALLAN, NICHOLAS PAUL Columbus, OH 2024
NOFO Title: HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R34 Clinical Trial Optional)
NOFO Number: RFA-AA-23-006